CAMBRIDGE ALLERGY LTD

Active Gosport

Research and experimental development on biotechnology

11 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
C

CAMBRIDGE ALLERGY LTD

Research and experimental development on biotechnology

Founded 7 Dec 2015 Active Gosport, England 11 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 4 Jun 2026 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 20 Dec 2025 Next due 20 Dec 2026 6 months remaining
Net assets £284K £292K 2024 year on year
Total assets £660K £198K 2024 year on year
Total Liabilities £376K £94K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Hoeford Point Barwell Lane Gosport Hampshire PO13 0AU England

Website

www.example.com

Full company profile for CAMBRIDGE ALLERGY LTD (09905065), an active life sciences and medical technology company based in Gosport, England. Incorporated 7 Dec 2015. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2016–2024)

Cash in Bank

£110.50k

Decreased by £68.91k (-38%)

Net Assets

£284.09k

Decreased by £291.75k (-51%)

Total Liabilities

£375.60k

Increased by £93.66k (+33%)

Turnover

N/A

Employees

11

Decreased by 3 (-21%)

Debt Ratio

57%

Increased by 24 (+73%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2
Grants 3

Investors (3)

Investor NameInvestor SinceParticipating Rounds
Investor 2Dec 2017Seed
Investor 3Dec 2017Seed
Investor 4Dec 2023Crowdfunding

Share Capital

Share Capital

Share allotments and capital structure

29 Allotments 1,783,592 Shares £5.73m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
12 May 20263,766£0.377£0
1 Sept 20252,066£0.207£0
4 Jul 2025686,554£473k£0.689
16 May 2025105,300£58k£0.551
16 May 20252,745£2k£0.689

Officers

Officers

1 active 2 resigned
Status
Pamela Wilson EwanDirectorBritishEngland8013 Oct 2017Active

Shareholders

Shareholders (38)

Cambridge University Hospitals Nhs Foundation Trust
19.7%
653,007
Syndicate Room Nominees Ltd
11.6%
384,092

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Jonathan Simon Milner

Ceased 4 Jul 2023

Ceased

Group Structure

Group Structure

CAMBRIDGE ALLERGY LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
4 Jun 2026AccountsAnnual accounts made up to 31 Dec 2025
14 May 2026CapitalAllotment of shares (GBP 332.2376) on 12 May 2026
20 Dec 2025OfficersChange to director Mr Edward Smith on 16 May 2025
20 Dec 2025Confirmation StatementConfirmation statement made on 6 Dec 2025 with updates
18 Dec 2025OfficersAppointment of Mr David Allan Newble as director on 1 Dec 2025
4 Jun 2026 Accounts

Annual accounts made up to 31 Dec 2025

14 May 2026 Capital

Allotment of shares (GBP 332.2376) on 12 May 2026

20 Dec 2025 Officers

Change to director Mr Edward Smith on 16 May 2025

20 Dec 2025 Confirmation Statement

Confirmation statement made on 6 Dec 2025 with updates

18 Dec 2025 Officers

Appointment of Mr David Allan Newble as director on 1 Dec 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

4 days ago on 4 Jun 2026

Allotment of shares (GBP 332.2376) on 12 May 2026

3 weeks ago on 14 May 2026

Change to director Mr Edward Smith on 16 May 2025

5 months ago on 20 Dec 2025

Confirmation statement made on 6 Dec 2025 with updates

5 months ago on 20 Dec 2025

Appointment of Mr David Allan Newble as director on 1 Dec 2025

5 months ago on 18 Dec 2025